Medico Intercontinental Ltd
Medico Intercontinental Ltd Formerly Known as M/S. Intercontinental Leasing & Finance Company Limited) was incorporated in 1984. Currently, they are providing a platform to all research based biopharmaceutical companies reaching their Novel and innovative therapies. The Company is into the business of trading various medicines. [1] [2]
- Market Cap ₹ 44.2 Cr.
- Current Price ₹ 44.2
- High / Low ₹ 122 / 39.0
- Stock P/E 21.9
- Book Value ₹ 35.2
- Dividend Yield 0.23 %
- ROCE 10.9 %
- ROE 8.10 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company is almost debt free.
- Company is expected to give good quarter
Cons
- Company has a low return on equity of 12.5% over last 3 years.
- Company has high debtors of 186 days.
- Working capital days have increased from 93.7 days to 157 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00 | 0.02 | 0.27 | 0.23 | 2.03 | 0.00 | 9.95 | 46.93 | 41.02 | 39.25 | 48.88 | 56.61 | |
0.00 | 0.00 | 0.00 | 0.27 | 0.32 | 1.97 | 0.34 | 9.27 | 44.73 | 38.68 | 36.98 | 46.38 | 53.99 | |
Operating Profit | 0.00 | 0.00 | 0.02 | 0.00 | -0.09 | 0.06 | -0.34 | 0.68 | 2.20 | 2.34 | 2.27 | 2.50 | 2.62 |
OPM % | 100.00% | 0.00% | -39.13% | 2.96% | 6.83% | 4.69% | 5.70% | 5.78% | 5.11% | 4.63% | |||
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.05 | 0.39 | 0.36 | 0.02 | 0.16 | 0.18 | 0.34 | 0.55 | |
Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.66 | 0.78 | 0.52 | 0.37 | 0.17 |
Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 | 0.06 | 0.10 | 0.09 | 0.17 |
Profit before tax | 0.00 | 0.00 | 0.02 | 0.00 | -0.09 | 0.01 | 0.05 | 1.03 | 1.54 | 1.66 | 1.83 | 2.38 | 2.83 |
Tax % | 50.00% | 33.33% | 0.00% | 40.00% | 26.21% | 27.27% | 27.71% | 28.42% | 28.15% | ||||
0.00 | 0.00 | 0.01 | 0.00 | -0.06 | 0.01 | 0.03 | 0.76 | 1.12 | 1.20 | 1.31 | 1.70 | 2.02 | |
EPS in Rs | 0.00 | 0.00 | 0.40 | 0.00 | -0.18 | 0.03 | 0.09 | 2.34 | 3.45 | 3.69 | 4.03 | 1.70 | 2.02 |
Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 5.88% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | 1% |
TTM: | 66% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | 124% |
3 Years: | 15% |
TTM: | 42% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | -16% |
3 Years: | -1% |
1 Year: | -41% |
Return on Equity | |
---|---|
10 Years: | 11% |
5 Years: | 15% |
3 Years: | 12% |
Last Year: | 8% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Sep 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 0.25 | 0.25 | 0.25 | 3.25 | 3.25 | 3.25 | 3.25 | 3.25 | 3.25 | 3.25 | 3.25 | 10.00 | 10.00 |
Reserves | 0.03 | 0.02 | 0.04 | 0.04 | -0.02 | -0.01 | 0.02 | 0.78 | 1.90 | 3.09 | 4.40 | 24.30 | 25.16 |
0.02 | 0.02 | 0.02 | 0.02 | 0.23 | 0.02 | 0.02 | 0.09 | 8.56 | 4.81 | 6.21 | 2.27 | 3.14 | |
0.00 | 0.01 | 0.01 | 0.02 | 0.07 | 0.93 | 0.62 | 5.00 | 5.46 | 5.27 | 3.85 | 7.81 | 3.59 | |
Total Liabilities | 0.30 | 0.30 | 0.32 | 3.33 | 3.53 | 4.19 | 3.91 | 9.12 | 19.17 | 16.42 | 17.71 | 44.38 | 41.89 |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.00 | 0.12 | 0.24 | 0.20 | 0.48 | 0.42 | |
CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.03 | 3.57 | 4.35 | 4.20 | 4.20 | 4.20 |
0.30 | 0.30 | 0.32 | 3.33 | 3.53 | 4.18 | 3.90 | 9.09 | 15.48 | 11.83 | 13.31 | 39.70 | 37.27 | |
Total Assets | 0.30 | 0.30 | 0.32 | 3.33 | 3.53 | 4.19 | 3.91 | 9.12 | 19.17 | 16.42 | 17.71 | 44.38 | 41.89 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00 | -2.96 | 0.12 | -0.04 | 0.02 | 0.95 | -6.55 | 5.44 | 1.10 | -11.95 | ||
0.00 | 0.00 | 0.00 | 0.00 | -0.01 | 0.00 | -0.03 | -3.68 | -0.94 | -0.80 | -5.02 | ||
0.00 | 0.00 | 3.00 | 0.00 | 0.00 | 0.00 | 0.07 | 9.22 | -4.51 | 0.87 | 20.63 | ||
Net Cash Flow | 0.00 | 0.00 | 0.04 | 0.12 | -0.05 | 0.02 | 0.99 | -1.01 | -0.02 | 1.17 | 3.66 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 0.00 | 0.00 | 79.35 | 339.83 | 237.34 | 98.54 | 71.45 | 78.86 | 186.08 | |||
Inventory Days | 0.00 | 0.00 | 0.00 | 0.00 | 25.84 | 22.28 | 36.32 | 26.47 | 31.98 | |||
Days Payable | 200.54 | 45.26 | 51.21 | 39.76 | 64.82 | |||||||
Cash Conversion Cycle | 0.00 | 0.00 | 79.35 | 339.83 | 62.63 | 75.57 | 56.56 | 65.57 | 153.24 | |||
Working Capital Days | 4,927.50 | 4,380.00 | 5,125.87 | 345.22 | 78.50 | 76.45 | 57.13 | 66.86 | 157.11 | |||
ROCE % | 0.00% | 0.00% | 6.67% | 0.00% | -2.66% | 1.79% | 1.53% | 28.07% | 24.68% | 19.63% | 18.79% | 10.91% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Change in Directorate
2d - Appointment of Mr. Parshwa Kaushal Shah (DIN: 07400081) as an Additional Independent Director.
- Shareholding Meeting / Postal Ballot - Notice Of Postal Ballot 2d
- Board Meeting Outcome for Outcome Of Board Meeting And Compliances Of Regulation 30 Of SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015. 2d
-
Update on board meeting
6 May - The Board Meeting to be held on 07/05/2024 has been revised to 10/05/2024 The Board Meeting to be held on 07/05/2024 has been revised to …
- Board Meeting Intimation for Compliance Of Regulation 29 Of The SEBI (LODR) Regulations, 2015 30 Apr
About[1]
Medico is engaged in trading of Pharmaceutical products. In past few years, their core portfolio has been textile products. Current management brings expertise in the pharma industry and so the company has diversified to a pharma company.